Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre,single-arm,phase 2 trial with a safety run-in |
| |
| Affiliation: | 1. Sir Charles Gairdner Hospital, Nedlands, WA, Australia;2. National Centre for Asbestos Related Diseases, Perth, WA, Australia;3. Medical School, University of Western Australia, Perth, WA, Australia;4. School of Biomedical Sciences, University of Western Australia, Perth, WA, Australia;5. National Health and Medical Research Council, Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia;6. The Prince Charles Hospital and University of Queensland, Brisbane, QLD, Australia;7. University of Queensland, Brisbane, QLD, Australia;8. Nepean Hospital, Kingswood, NSW, Australia;9. Olivia Newton-John Cancer Research Institute, Austin Hospital, Heidelberg, VIC, Australia;10. Chris O''Brien Lifehouse, Camperdown, NSW, Australia;11. PathWest Laboratory Medicine, Nedlands, WA, Australia;12. Royal North Shore Hospital and Northern Cancer Institute, Sydney, NSW, Australia;13. Mid North Coast Cancer Institute, Coffs Harbour Health Campus, Coffs Harbour, NSW, Australia;14. Princess Alexandra Hospital and Queensland University of Technology, Brisbane, QLD, Australia;15. Flinders Medical Centre and Flinders University, Bedford Park, SA, Australia;p. Department of Medical Oncology, Fiona Stanley Hospital and Western Australia Country Health Service, Perth, WA, Australia |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
